SEKISUI Diagnostics launches OSOM Ultra Plus Flu A&B Test

SEKISUI Diagnostics has launched the OSOM Ultra Plus Flu A&B Test. The test utilizes traditional lateral flow technology with performance near or exceeding sensitivity of other reader-based tests without using an instrument. It is intended for the qualitative detection of influenza type A and type B nucleoprotein antigens directly from nasal or nasopharyngeal swab specimens from patients with signs and symptoms of respiratory infection.

 

High performance, point-of-care rapid test for the detection of Influenza A&B

• Simple CLIA-waived procedure with pre-measured extraction buffer for swab samples
• Accurate, differentiated interpretation of results in 10 minutes to test and treat patients in one office visit
• Sensitivity
  • A: 90.3%
  • B: 88.0%
• Specificity
  • A: 96.7%
  • B: 99.2%